The Myelodysplastic Syndromes (MDS) Foundation
The Myelodysplastic Syndromes (MDS) Foundation was created by a group of international physicians and researchers who wanted to make sure that information about MDS was always available. Now, the organization has developed to include patient advocacy groups, research funding, and educational initiatives. In addition, the MDS Foundation works to set up an international information network to contact patients for available clinical trials, thus sharing new treatment options in the community.
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Connect With The Myelodysplastic Syndromes (MDS) Foundation
Patient Worthy Posts on Myelodysplastic syndromes
New Phase I/II Trial for Myelodysplastic Syndrome, Acute Myeloid Leukemia, and Multiple Myeloma is Now Underway!
The very first patient in Medigene AG’s clinical trial examining MDG1011 has officially received the treatment. This is the company’s first human clinical trial for
What is the Patient Advocate Foundation? The Patient Advocate Foundation (PAF) is a non-profit, formed in 1994 that has one primary aim- eliminate the barriers
The government shutdown hasn’t had any startling affects on rare disease research yet, but drug developers have voiced their concern that it could soon begin
Myelodysplastic syndromes (MDS) is the name used to describe a group of stem cell disorders in which the body can’t produce an adequate amount of
According to a story from Science and Technology Research News, a group of researchers from the Cleveland Clinic led by Dr. Aziz Nazha will soon